BIOMAT Database Logo BIOMAT Database Logo

[Induction of specific resistance in Swiss mice using x-irradiated cells of the ATPC+ ascitic tumor]. 1973

P Marconi, and E Fimiani, and F Bistoni, and A Latini

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D005260 Female Females
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor

Related Publications

P Marconi, and E Fimiani, and F Bistoni, and A Latini
[Solubilization of antigens from ATPC+ ascitic tumor using hypertonic sodium solution].
May 1973, Bollettino della Societa italiana di biologia sperimentale,
P Marconi, and E Fimiani, and F Bistoni, and A Latini
[Natural resistance and induced resistance to ATPC + tumor in mice].
January 1972, Bollettino dell'Istituto sieroterapico milanese,
P Marconi, and E Fimiani, and F Bistoni, and A Latini
[Oncogenic capacity of the ATPC+ ascites tumor inoculated by various routes in Swiss mice].
November 1971, Bollettino della Societa italiana di biologia sperimentale,
P Marconi, and E Fimiani, and F Bistoni, and A Latini
[Self-enhancement in allografts of an aspecific ascitic tumor (ATPC+)].
January 1967, Lavori dell'Istituto di anatomia e istologia patologica, Universita degli studi di Perugia,
P Marconi, and E Fimiani, and F Bistoni, and A Latini
[The effect of membrane-active compounds on the radiation-modifying effect of glucose in x-irradiated ascitic tumor cells].
January 1991, Radiobiologiia,
P Marconi, and E Fimiani, and F Bistoni, and A Latini
Effects of x-irradiated tumor cells on spontaneous mammary tumor recurrences in C3H mice.
March 1962, Growth,
P Marconi, and E Fimiani, and F Bistoni, and A Latini
Tumor induction study with allylhydrazine HCl in swiss mice.
July 1976, British journal of cancer,
P Marconi, and E Fimiani, and F Bistoni, and A Latini
Effect of iododeoxyuridine on tumor induction in X-irradiated rats.
June 1975, Experientia,
P Marconi, and E Fimiani, and F Bistoni, and A Latini
Growth Induction of Solid Ehrlich Ascitic Carcinoma in Mice after Proton Irradiation of Tumor Cells Ex Vivo.
August 2023, Doklady. Biochemistry and biophysics,
P Marconi, and E Fimiani, and F Bistoni, and A Latini
[Antibodies to the autologous tumor cells in tumor induction in mice using methylcholanthrene].
January 1974, Voprosy onkologii,
Copied contents to your clipboard!